Skip to content
Riskpilot
← Back to search
Sign in
Get full access
Postviral Research Stockholm AB
AB
In liquidation
Org 5594246984
Stockholm
Other research and experimental development on natural sciences and engineering
· NACE 7219
Est. 2023
0 employees
Watchlist
Share
Sweden
/
Companies
/
Other research and experimental development on natural sciences and engineering
/
Postviral Research Stockholm AB
Overview
Financials
People & ownership
Related companies
Loading company…
People & ownership
Management
Actively employed in the business
Name
Role
Member since
Current (1)
HE
Hans Erik Peter Hansson
Liquidator
Liquidator
2024
Board of directors
Non-executive oversight
Name
Role
Member since
Former (19)
JA
Jan Anders Fredrik Lovén
Deputy Board Member
2023 – 2023
JT
Jan Totte Dahlin
Deputy Board Member
2023 – 2023
VE
Viktor Elias Bergman Gullmark
Deputy Board Member
2023 – 2023
AH
Andreas Hans Eddie Ottosson
Deputy Board Member
2023 – 2023
AM
Anna Matilda Sjödin
Deputy Board Member
2023 – 2023
AC
Anna Camilla Biström
Deputy Board Member
2023 – 2023
LA
Lars Anders Larsson
Board of Directors
2023 – 2023
LM
Linn Mikaela Engman
Deputy Board Member
2023 – 2023
ES
Emelie Sofia Bergh
Deputy Board Member
2023 – 2023
KJ
Karl Jonas Axelsson
Board of Directors
2023 – 2024
AC
Anna Carolina Maria Bjarnhagen
Deputy Board Member
2023 – 2023
EA
Elin Anna Margareta Spjut
Deputy Board Member
2023 – 2023
EE
Eva Evelina Evelyn Sjöstedt
Deputy Board Member
2023 – 2023
MS
Mari Sinikka Kovaniemi Feldt
Deputy Board Member
2023 – 2023
JO
Johan Olof Cervin
Chairman
2023 – 2024
OK
Olina Kristina Maria Wåhlstedt
Deputy Board Member
2023 – 2023
JH
Johan Hugo Andreas Cervin
Deputy Board Member
2024 – 2024
JE
Julia Engla Eva M Arnfridsdotter
Deputy Board Member
2023 – 2023
AK
Anna Klara Alina Bruksås Nybjörk
Deputy Board Member
2023 – 2023
Shareholders
As of last annual report
Shareholder
Type
Ownership
Votes
Since
South End AB
Company
100%
100%
2024
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive.
Learn more
.
More on Postviral Research Stockholm AB
Overview →
Headline figures, risk assessment and company summary
Financials & key figures →
Revenue, EBITDA, balance sheet and 5-year trend
Related companies →
Corporate hierarchy, parent and subsidiary network